436 related articles for article (PubMed ID: 10811879)
1. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.
Small GW; Ercoli LM; Silverman DH; Huang SC; Komo S; Bookheimer SY; Lavretsky H; Miller K; Siddarth P; Rasgon NL; Mazziotta JC; Saxena S; Wu HM; Mega MS; Cummings JL; Saunders AM; Pericak-Vance MA; Roses AD; Barrio JR; Phelps ME
Proc Natl Acad Sci U S A; 2000 May; 97(11):6037-42. PubMed ID: 10811879
[TBL] [Abstract][Full Text] [Related]
2. Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
Ercoli L; Siddarth P; Huang SC; Miller K; Bookheimer SY; Wright BC; Phelps ME; Small G
Arch Gen Psychiatry; 2006 Apr; 63(4):442-8. PubMed ID: 16585474
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
4. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.
Mosconi L; Perani D; Sorbi S; Herholz K; Nacmias B; Holthoff V; Salmon E; Baron JC; De Cristofaro MT; Padovani A; Borroni B; Franceschi M; Bracco L; Pupi A
Neurology; 2004 Dec; 63(12):2332-40. PubMed ID: 15623696
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
6. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
Small GW; Siddarth P; Burggren AC; Kepe V; Ercoli LM; Miller KJ; Lavretsky H; Thompson PM; Cole GM; Huang SC; Phelps ME; Bookheimer SY; Barrio JR
Arch Gen Psychiatry; 2009 Jan; 66(1):81-7. PubMed ID: 19124691
[TBL] [Abstract][Full Text] [Related]
7. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
8. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
Mosconi L; Nacmias B; Sorbi S; De Cristofaro MT; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A
J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):370-6. PubMed ID: 14966149
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
[TBL] [Abstract][Full Text] [Related]
12. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
[TBL] [Abstract][Full Text] [Related]
13. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele).
Scarmeas N; Habeck C; Anderson KE; Hilton J; Devanand DP; Pelton GH; Tabert MH; Flynn J; Park A; Ciappa A; Tycko B; Stern Y
Am J Geriatr Psychiatry; 2004; 12(6):596-605. PubMed ID: 15545327
[TBL] [Abstract][Full Text] [Related]
14. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
15. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
[TBL] [Abstract][Full Text] [Related]
16. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):284-9. PubMed ID: 14688411
[TBL] [Abstract][Full Text] [Related]
17. Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.
Hirono N; Mori E; Yasuda M; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Sasaki M
Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):362-7. PubMed ID: 9876966
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
Wolk DA; Dickerson BC;
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
[TBL] [Abstract][Full Text] [Related]
19. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]